Dear Editor:

Cutaneous metastasis from osteosarcoma is exceedingly rare, with only 11 cases reported in the literature[@B1]. Giant cell--rich osteosarcoma is a rare variant of osteosarcoma, accounting for 1%\~3% of conventional osteosarcomas[@B2]. Herein, we present the rare case of a patient with cutaneous metastasis of giant cell--rich osteosarcoma, which closely resembled a giant cell tumor. Owing to the different prognoses and treatment strategies for these tumors, it is important to ensure that the correct differential diagnosis is made.

A 43-year-old man presented with a 6-month history of nodules on his scalp. He had been diagnosed with giant cell-rich osteosarcoma in his right femur along with metastases to multiple organs, including the lungs and the mandible, 1 year ago. The metastatic lung nodules had increased in size despite 6 months of chemotherapy with ifosfamide, adriamycin, and high-dose methotrexate. Subsequently, oncologists changed the regimen to gemcitabine and docetaxel, but the tumor still progressed. Therefore, the regimen was changed once again, and he was admitted to receive a second cycle of cyclophosphamide and etoposide as a third-line regimen.

Upon physical examination, several firm skin-colored to erythematous nodules were palpated on his scalp, each measuring approximately 5\~12 mm ([Fig. 1](#F1){ref-type="fig"}). Histopathological findings showed many uniformly distributed, multinucleated giant cells containing pleomorphic nuclei. Mononuclear tumor cells had hyperchromatic nuclei with a variety of morphologies, such as round, oval, polygonal, and spindle-shaped ([Fig. 2](#F2){ref-type="fig"}). Although atypical mitoses or dominant osteoid formations were hardly observed, these histological findings were consistent with those of giant cell-rich osteosarcoma, which was previously confirmed by right femur biopsy ([Fig. 2](#F2){ref-type="fig"}). Three months later, he died of sepsis following bone marrow failure caused by the continued chemotherapy.

Several studies have reported that giant cell-rich osteosarcomas are sometimes misdiagnosed as giant cell tumors because of their similar clinicopathological features[@B2][@B3][@B4]. However, these tumors have extremely different clinical courses and prognoses. Giant cell tumors are usually benign with a metastatic rate of \<2%, while the clinical course of osteosarcoma is extremely aggressive, with rapid hematogenous systemic dissemination and a tumor-related mortality of 75% within 5 years of diagnosis[@B1][@B5].

For these reasons, Huang et al.[@B3] suggested the use of some key factors to distinguish these two tumors, including osteoid formation, nuclear pleomorphism, and atypical mitotic figures[@B3]. However, osteoid formation cannot be found in small biopsy samples or samples from early lesions[@B4]. Tumor cell pleomorphism is not obvious in some cases[@B2]. Unless malignant osteoid formation is found, as in this case, it is difficult to confirm an osteosarcoma diagnosis without knowing a patient\'s cancer history. Unfortunately, not all cases present with features as informative as those in the case reported here.

Among 29 cases of giant cell-rich osteosarcoma, only 1 case of cutaneous metastasis had been reported in English literature[@B2][@B3][@B4]. With the histological similarity to giant cell tumors, this case emphasizes the value of careful examination of tumor cell pleomorphism and pathological mitoses when patients present with giant cell-rich tumors.

![Three 5 to 12-mm, flesh-toned to erythematous, firm nodules on the scalp (arrows).](ad-28-247-g001){#F1}

![(A) Hypercellular stroma composed of mononuclear tumor cells and many multinucleated giant cells (H&E, ×40). (B) Mononuclear tumor cells with a variety of morphologies and multinucleated giant cells containing large pleomorphic nuclei (H&E, ×400). (C) Primary tumor of the right femur; numerous multinucleated giant cells and atypical tumor cells (H&E, ×400).](ad-28-247-g002){#F2}
